SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-007936
Filing Date
2021-04-05
Accepted
2021-04-05 08:51:15
Documents
8
Period of Report
2021-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 35687
2 ex99-1.htm EX-99.1 125516
3 ex99-2.htm EX-99.2 181037
4 ex99-3.htm EX-99.3 17629
5 ex99-1_001.jpg GRAPHIC 23791
6 ex99-2_001.jpg GRAPHIC 31411
7 ex99-2_002.jpg GRAPHIC 11667
8 ex99-3_001.jpg GRAPHIC 23791
  Complete submission text file 0001493152-21-007936.txt   486441
Mailing Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 21803842
SIC: 2834 Pharmaceutical Preparations